Tanabe Pharma America

Tanabe Pharma America is a pharmaceutical company headquartered in Jersey City, New Jersey. Launched in 2016 as a wholly-owned subsidiary of Tanabe Pharma Corporation, one of the world's oldest pharmaceutical companies with over 300 years of history, the company is charged with developing and advancing its pipeline as well as commercializing approv... ed pharmaceutical products in North America. Tanabe Pharma America focuses on tackling complex and debilitating conditions, with a commitment to meeting the needs of people suffering from serious and often life-threatening illnesses. The company's primary therapeutic areas include amyotrophic lateral sclerosis and Parkinson's disease, where it drives scientific discovery and innovation through a robust late-stage pipeline of investigational treatments for difficult-to-treat diseases. Tanabe Pharma America works diligently to develop safe and effective treatments for devastating illnesses, building on its parent company's legacy of discovering and producing several first-in-class medicines for serious diseases including multiple sclerosis, diabetes mellitus, and amyotrophic lateral sclerosis. The company registers and discloses information on publicly accessible clinical trial registries and contributes to a deeper understanding of complex diseases by sharing findings with the scientific community. Previously known as Mitsubishi Tanabe Pharma America, the company rebranded to Tanabe Pharma America in December 2025.Read More